01.11.2004
Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: Anticholinergic drugs and botulinum toxin as additional therapeutic options
Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2004
Einloggen, um Zugang zu erhalten